-
November 19, 2019 Lupin launches generic KCl for Oral Solution USP, 20 mEq
-
November 11, 2019 Lupin enters into agreement to divest its stake in Kyowa to Unison
-
November 8, 2019 Lupin receives US FDA approval for Zileuton Extended-Release Tablets
-
November 7, 2019 Dr. Desh Bandhu Gupta AAiPS Award 2019 Conferred on Dr. Umesh Gupta
-
November 6, 2019 Lupin Quarter II, FY 2020 Results
-
November 1, 2019 Lupin receives sANDA approval from US FDA for Levothyroxine Sodium Tablets USP AB rating to Reference Listed Drug, LEVOXYL®
-
October 23, 2019 Notice of Q2 FY2020 Board Meeting
-
October 22, 2019 Lupin receives U.S. FDA approval for Divalproex Sodium ER Tablets USP
-
October 18, 2019 Lupin’s Nagpur facility receives EIR from the U.S. FDA
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications